section name header

Use and Dosing

Adult Dosingnavigator.gif

Inhalational anthrax due to bacillus anthracis

Pediatric Dosingnavigator.gif

Inhalational anthrax due to bacillus anthracis

Note:Safety and effectiveness in children <16 years of age not studied. There have been no studies of raxibacumab in the pediatric population. Dosing in pediatric patients was derived using a population PK approach.

[Outline]

Indications

Contraindications

Black Box Warnings

N/A

Dosing Adjustment

Renal Dose Adjustment (Based on CrCl)

Hepatic Dose Adjustment

Warnings/Precautions

Pregnancy/Breast Feeding

Pregnancy Category:B

Breastfeeding: Human immunoglobulins are excreted in human milk, published data suggest that neonatal consumption of human milk does not result in substantial absorption of these maternal immunoglobulins into circulation, however caution should be exercised when administered to a nursing woman

Adverse Reactions

Clinical Pharmacology

Brands and Availability

flag_usa32.png

US Trade Name(s)

US Availability

raxibacumab (generic)

flag_canada32.png

Canadian Trade Name(s)

Canadian Availability

flag_uk32.png

UK Trade Name(s)

UK Availability

flag_australia32.png

Australian Trade Name(s)


[Outline]

flag_usa32.pngflag_canada32.pngflag_uk32.pngflag_australia32.png

Classification

Emergency/Critical Care

Other Antidotes